MolNFT v1 · #63308 · protein
C2 crystal form of mite allergen der P 1
3F5V · Der P 1 allergen: “C2 crystal form of mite allergen der P 1”. X-ray diffraction, 1 ligand (CA), 1 pocket (best druggability 0.71). MolNFT v1 #63308 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3F5V
- Type
- protein
- Length
- 444 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Der P 1 allergen
- EC
- 3.4.22.65
- UniProt
- Q3HWZ5
- Ligands
- CA
- Pockets
- 1 · best druggability 0.71
Structure
x-ray diffraction · 1 distinct chain · 28% helix, 25% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Der P 1 allergen (EC 3.4.22.65) | protein | 222 | 28% helix, 25% strand | Q3HWZ5 |
Ligands and binding sites
- CA · Calcium ion · metal · 2 copies · chains A, B
- P6G · Hexaethylene glycol · additive · 5 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 639 | 0.71 | 0.78 | 64 | P6G |
Interfaces
1 interface between chains.
- A–B · 660 Ų buried · 10 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 6 disulfide, 2 modified (disulfide, oxidation).
Compared structures
- 3F5V · C2 Crystal form of mite allergen DER P 1 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q3HWZ5
- Elsewhere: RCSB PDB 3F5V · PDBe 3F5V · UniProt Q3HWZ5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.